US Archives - Page 43 of 165 - European Medical Journal

Machine Learning Improves Prediction of Urgent Care in Lung Cancer

Machine learning can help predict urgent care visits in patients with non–small cell lung cancer receiving systemic therapy.

23 Sep 2025

IL-5 in Focus: A New View on Type 2 Inflammation

This interactive infographic explores how IL-5 contributes to Type 2 inflammation in severe asthma. Discover IL-5’s effects on immune cells beyond eosinophils, and the clinical consequences.

Signals in Blood and Spinal Fluid Linked to Cerebral Palsy Risk

Could molecules in the blood and spinal fluid hold the key to understanding cerebral palsy?

Canakinumab Outperforms Anakinra in VEXAS Syndrome

Canakinumab demonstrated significantly greater efficacy and durability than anakinra in the treatment of patients with VEXAS syndrome, according to findings from an international multicenter study.

Oral Health Still Burdens Long-Term Cancer Survivors

Long-term head and neck cancer survivors frequently report poor oral health-related quality of life, with persistent late toxicities remaining common more than 8 years after diagnosis.

Combined Brain Stimulation and Therapy Boosts Stroke Recovery

Patients with aphasia caused by stroke or traumatic brain injury experienced the greatest improvements in language recovery when transcranial direct current stimulation (tDCS) was combined with speech-language therapy (SLT).

Cigarette Smoke Found to Impair Stem Cell Function

Cigarette smoke significantly impairs the regenerative functions of mesenchymal stem cells (MSCs), raising critical concerns for their therapeutic use in regenerative medicine, according to a new review.

Hidden Oxygen Drops Linked to Child Sleepiness

Children with sleep-disordered breathing who experience a higher hypoxic burden show stronger links to sleepiness and disease severity, according to new research.

Psoriasis Burden in Youth Rising Globally

The global burden of psoriasis among adolescents and young adults has increased steadily over the past three decades, with projections indicating further acceleration through 2035.

Real-World PEDISTAD Study Explores Pediatric Atopic Dermatitis

Children under 12 years with moderate to severe atopic dermatitis experienced varying outcomes with systemic therapies, according to new real-world data from the PEDISTAD registry.